Healthcare
Vertex Pharmaceuticals Incorporated
VRTX$528.90-3.15%
Price is delayed.
Add to watchlist
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals dominates the cystic fibrosis drug market. Their treatments have transformed the lives of patients with this genetic disease. The company is expanding into pain management and other rare diseases. They have one of the strongest growth profiles in biotech.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore